NCT01075321 2020-10-22
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Mayo Clinic
Phase 1/2 Completed
Mayo Clinic
OHSU Knight Cancer Institute
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)